Edwards Lifesciences 2005 Annual Report"
The Carpentier-Edwards PERIMOUNT Magna valve is the leading heart valve in the U.S. and the first and only therapy of its kind to combine more than two decades of clinical experience and innovation with Edwards' advanced tissue treatment technologies.
The Cribier-Edwards percutaneous tissue valve is designed to treat patients with severe aortic heart valve stenosis by threading a replacement heart valve via a catheter through the patient's circulatory system.
The Edwards FloTrac sensor enables clinicians to less invasively monitor important hemodynamic performance parameters. Edwards’ PreSep catheter is used in managing patients with severe sepsis, the spread of an infection to the bloodstream.